Khiron Life Sciences (KHRN) Stock Price, News & Analysis

Company Overview

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.04 to C$0.05
• 50-Day Range: C$0.04 to C$0.04
• 52-Week Range: C$0.04 to C$0.21
• Volume: 24,000 shs
• Average Volume: 256,268 shs
• Market Capitalization: C$9.30 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: CVE:KHRN
• CIK: N/A
• Web: www.khiron.ca
• Phone: 705-527-3564
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.20)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -C$46.80 million
• Net Margins: -258.92%
• Pretax Margin: N/A
• Return on Equity: -68.62%
• Return on Assets: -20.79%

Debt

• Debt-to-Equity Ratio: 6.68
• Current Ratio: 3.08
• Quick Ratio: 0.72

Sales & Book Value

• Annual Sales: C$18.08 million
• Price / Sales: 0.51
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 6.67
• Book Value: C$0.20 per share
• Price / Book: 0.20

Miscellaneous

• Outstanding Shares: 232,409,000
• Free Float: N/A
• Market Cap: C$9.30 million
• Optionable: Not Optionable
• Beta: 2.64